Member Info for optimist13

Torchlight paid £4m for KCR shares at 45p per share, which in itself was a substantial discount to the previous placing by the company. I paid 22p this morning for shares which I hope will prove to be the low when the Interim Report is released.

My main reason for posting this information here is that I believe/hope that liquidity will significantly improve in KCR shares which will allow Drumz to sell their 2.435m shares at a significant premium to the current book value.

Mike Joseph
@benchpressmike
Exciting times ahead @AGA_Plc
, not long now until the RTO of #aaap with @ComarcoGroup
, then the real story begins . Massive upside opportunity, no wonder I chose to buy around 29% of AAAP
10:36 AM · Mar 24, 2021·Twitter for iPhone
1
Retweet
1
Quote Tweet
3
Likes

From the KCR previous year results:

"A detailed review of existing assets has been completed and we have taken significant steps to "right size" the cost base. Solid progress has been made, with substantial further improvements expected during the current full year to June 2021. The majority of the restructuring costs have been incurred and expensed during the current financial year and first half of the current year will reflect the reductions made to date."

Well, they were sounding positive back in September, so the solid progress should help the share price of Drumz.

Just bought a few KCR shares at what looks like an all time low. With the interim report due next week, I may have timed it about right which doesn't often happen.

Due next week. Should be a significant improvement over the previous year.

Invested in Drumz who hold 8% of the shares here, so interested to see how the market reacts if the news is positive from the company.

Bought a few this morning, which looks to be an all time low.

Looking at the KCR Residential interim results for last year, the company reported a loss of £2.5m for the period in question. Since then there have been changes to the company as well as a significant capital injection by Torchlight Fund.

I would expect to see a material change in the current year which should lead to a higher NAV.

MrTHC, thanks for the link. A decent overview of where the fledgling Cannabis market is at the moment and decent PR for Apollon.

Interesting to read about the listed stocks being shorted, which will not be allowed on Aquis Exchange. The fact that the placing was also heavily oversubscribed should also give Apollon a lift when the RTO becomes effective.

Hi Mike, good to hear from you. Yes, it is certainly taking a long time to conclude the RTO, but as you have said previously, the prospects are very bright for Comarco moving forward.

One of the main attractions for me is the fact that they already have the Port and the marine logistics to ramp up revenues significantly. Paying down the expensive debt will make a huge difference to the interest bill and balance sheet.

Just need confirmation of the RTO date now to ease any concerns LTH's may have.

http://www.afriagglobal.com/wp-content/uploads/2021/03/Apollon_Acquisition-FINAL.pdf

The new company will list on Aquis on the 13 April 2021.

12 month lock in period for the new BOD and Apollon shareholders.

https://www.investegate.co.uk/anglo-african-agriculture-plc--aaap-/prn/corporate-update-and-issue-of-convertible-loan-notes/20210323114648P68F0/

Yes, I think the KCR results will show a substantial improvement over the previous period and a realignment of the share price to reflect a fairer value to net assets.

Still believe Drumz will be able to sell their KCR holding off book at a higher value than the current asset valuation.

Well, that's the accounts released which should now facilitate the completion of the RTO.

Lots of information to digest from the accounts but Comarco still forecasting a substantial boost from the Mozambique LNG project, which after some delays, now appear to be on track and deliver revenues to Comarco over the next 10 years.

Apollon Formularies CEO Dr. Stephen Barnhill:

"Our conditional fundraise of £2,500,000, as announced on 23 February, has shown a strong appetite for our company and we are pleased that we are able to provide the market with a truly unique investment opportunity.”

I think there will be many more contract wins to follow. Acuity now appear to have the complete package for both large and small organisations alike. With many more employees working from home, cyber security must be at the forefront of everyone's minds.

https://www.lse.co.uk/news/samarkand-rises-18-on-first-day-of-dealings-on-aquis-stock-exchange-t8i4xvjqd77cq38.html

Just listened again to the Proactive Investors interview with Simon Phillips back in November 2019. I am sure everything discussed in the interview still holds good today and for any potential new investors, well worth a listen.

Further update on the RTO cannot be far away now.

https://www.comarcogroup.com/news/2019/proactive-interview/

Apollon Formularies
@apollon_uk
·
10m
Apollon’s strong research and development ability will make us one of the few listed cannabis companies in Europe that is able to treat patients with formulas inclusive of THC, and licences held in Jamaica mean that all our formulas are backed by medically supervised treatments.

Good to see the level of interest here. Sounds like there will be plenty of news flow in the coming weeks and months and I would imagine the acquisition of further brands following the success of the listing.

Apollon Formularies
@apollon_uk
·
15m
CEO Dr. Stephen Barnhill:

“We are delighted to be coming to market at such an important time for medical cannabis across the UK.

We look forward to bringing Apollon, with its full suite of licences and THC inclusive formulations, to the London market.

Good start to trading....140p paid.